Cytek Biosciences, Inc. CTKB Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s interest expense?
- Cytek Biosciences, Inc. (CTKB) reported interest expense of $262K in Q1 2026.
- How has Cytek Biosciences, Inc.'s interest expense changed year-over-year?
- Cytek Biosciences, Inc.'s interest expense decreased by 10.0% year-over-year, from $291K to $262K.
- What is the long-term trend for Cytek Biosciences, Inc.'s interest expense?
- Over 3 years (2021 to 2024), Cytek Biosciences, Inc.'s interest expense has grown at a 44.4% compound annual growth rate (CAGR), from $1.74M to -$5.24M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.